Yesen Li

989 total citations
45 papers, 766 citations indexed

About

Yesen Li is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Yesen Li has authored 45 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Radiology, Nuclear Medicine and Imaging, 19 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Yesen Li's work include Radiopharmaceutical Chemistry and Applications (16 papers), Nanoplatforms for cancer theranostics (8 papers) and Peptidase Inhibition and Analysis (7 papers). Yesen Li is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (16 papers), Nanoplatforms for cancer theranostics (8 papers) and Peptidase Inhibition and Analysis (7 papers). Yesen Li collaborates with scholars based in China, United States and Singapore. Yesen Li's co-authors include Xianzhong Zhang, Ting Liu, Zijing Li, Xiaolian Sun, Xiaohong Chen, Zhide Guo, Hua Wu, Yuhong Xu, Rongqiang Zhuang and Shi Gao and has published in prestigious journals such as Advanced Materials, Advanced Functional Materials and Analytical Chemistry.

In The Last Decade

Yesen Li

44 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yesen Li China 15 307 230 215 171 111 45 766
Hsin‐Ell Wang Taiwan 16 336 1.1× 198 0.9× 266 1.2× 145 0.8× 105 0.9× 37 940
Huiyun Zhao China 19 254 0.8× 458 2.0× 151 0.7× 263 1.5× 124 1.1× 38 894
Misu Lee South Korea 18 417 1.4× 129 0.6× 143 0.7× 177 1.0× 56 0.5× 59 961
Lingyi Sun China 12 258 0.8× 172 0.7× 106 0.5× 228 1.3× 108 1.0× 34 659
Mathew Robson United Kingdom 18 451 1.5× 198 0.9× 111 0.5× 153 0.9× 58 0.5× 30 901
D. Michael Olive United States 18 489 1.6× 231 1.0× 436 2.0× 157 0.9× 162 1.5× 27 1.1k
Jennifer H.E. Baker Canada 17 409 1.3× 128 0.6× 170 0.8× 300 1.8× 91 0.8× 43 933
Sarah M. Cheal United States 19 320 1.0× 490 2.1× 179 0.8× 285 1.7× 206 1.9× 36 1.0k
Hsin-Ell Wang Taiwan 23 506 1.6× 464 2.0× 368 1.7× 211 1.2× 176 1.6× 69 1.4k

Countries citing papers authored by Yesen Li

Since Specialization
Citations

This map shows the geographic impact of Yesen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yesen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yesen Li more than expected).

Fields of papers citing papers by Yesen Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yesen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yesen Li. The network helps show where Yesen Li may publish in the future.

Co-authorship network of co-authors of Yesen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yesen Li. A scholar is included among the top collaborators of Yesen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yesen Li. Yesen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Huifeng, Dongsheng Xia, Lingxin Meng, et al.. (2025). FAP-targeted delivery of radioiodinated probes: A progressive albumin-driven strategy for tumor theranostics. Journal of Controlled Release. 382. 113678–113678. 9 indexed citations
2.
Meng, Lingxin, Jianyang Fang, Rongqiang Zhuang, et al.. (2025). Development of radioligands with an albumin-binding moiety of 4-(P-Iodophenyl) butyric acid for theranostic applications. Journal of Controlled Release. 382. 113757–113757. 3 indexed citations
3.
Meng, Lingxin, Jianyang Fang, Jingru Zhang, et al.. (2024). Rational Design and Comparison of Novel 99mTc-Labeled FAPI Dimers for Visualization of Multiple Tumor Types. Journal of Medicinal Chemistry. 67(10). 8460–8472. 11 indexed citations
4.
Fang, Jianyang, Xiaobo Wang, Lingxin Meng, et al.. (2024). Preclinical Evaluation of 131I/18F-Labeled Covalent Small-Molecule Inhibitors for STING Status Imaging. ACS Pharmacology & Translational Science. 7(6). 1783–1794. 3 indexed citations
5.
Fang, Jianyang, Jingru Zhang, Lingxin Meng, et al.. (2024). 18F-Labeled Amidobenzimidazole Analogue for Visualizing STING Expression in Tumor. Molecular Pharmaceutics. 21(4). 1942–1951. 2 indexed citations
6.
Liang, Yuanyuan, Y. Wang, Yesen Li, et al.. (2024). A nitroreductase responsive probe for early diagnosis of pulmonary fibrosis disease. Redox Biology. 75. 103294–103294.
7.
Wen, Xuejun, Jia Liu, Xinying Zeng, et al.. (2023). In Vivo Comparative Study of Radioiodinated Folate Receptor Targeting Albumin Probes for Atherosclerosis Plaque Imaging. Bioconjugate Chemistry. 34(12). 2387–2397. 5 indexed citations
8.
Xu, Ling, Hu Chen, Pan He, et al.. (2023). 3D Hollow Porous Radio‐Granular Hydrogels for SPECT Imaging‐Guided Cancer Intravascular Brachytherapy. Advanced Functional Materials. 33(22). 7 indexed citations
9.
Xu, Xiao, Hu Chen, Yangjie Wang, et al.. (2023). Engineering Radioactive Microspheres for Intra‐Arterial Brachytherapy Using Radiation‐Induced Graft Polymerization. Advanced Functional Materials. 33(50). 12 indexed citations
10.
Wen, Xuejun, et al.. (2022). Novel Radiolabeled TMTP1 for Long-Acting Hepatocellular Carcinoma Therapeutics. Molecular Pharmaceutics. 19(9). 3178–3186. 4 indexed citations
11.
Liu, Huanhuan, Duo Xu, Jingchao Li, et al.. (2022). Radioiodinated Ethinylestradiol Derivatives for Estrogen Receptor Targeting Breast Cancer Imaging. ACS Medicinal Chemistry Letters. 13(2). 203–210. 3 indexed citations
12.
Wen, Xuejun, Changrong Shi, Yang Liu, et al.. (2021). A radioiodinated FR-β-targeted tracer with improved pharmacokinetics through modification with an albumin binder for imaging of macrophages in AS and NAFL. European Journal of Nuclear Medicine and Molecular Imaging. 49(2). 503–516. 17 indexed citations
13.
Xu, Duo, Xinying Zeng, Xuejun Wen, et al.. (2021). Radioiodinated 4-(p-Iodophenyl) Butanoic Acid-Modified Estradiol Derivative for ER Targeting SPECT Imaging. Analytical Chemistry. 93(41). 13998–14006. 13 indexed citations
14.
Li, Yesen, et al.. (2020). Synthesis and Application of a Long-Circulating Radiolabeled Peptide for Targeting of Osteosarcoma. Molecular Imaging and Biology. 22(4). 940–947. 6 indexed citations
15.
Du, Bulin, Chunrong Qu, Kun Qian, et al.. (2019). An IR820 Dye–Protein Complex for Second Near‐Infrared Window and Photoacoustic Imaging. Advanced Optical Materials. 8(4). 59 indexed citations
16.
Li, Lin, et al.. (2018). CpG-PEG Conjugates and their Immune Modulating Effects after Systemic Administration. Pharmaceutical Research. 35(4). 80–80. 3 indexed citations
17.
Fu, Hao, Hua Wu, Xianzhong Zhang, et al.. (2017). Pre-clinical study of a TNFR1-targeted 18F probe for PET imaging of breast cancer. Amino Acids. 50(3-4). 409–419. 10 indexed citations
18.
Sun, Xiaolian, Yesen Li, Ting Liu, et al.. (2016). Peptide-based imaging agents for cancer detection. Advanced Drug Delivery Reviews. 110-111. 38–51. 188 indexed citations
19.
Guo, Zhide, Deliang Zhang, Yesen Li, et al.. (2016). Simultaneous SPECT imaging of multi-targets to assist in identifying hepatic lesions. Scientific Reports. 6(1). 28812–28812. 12 indexed citations
20.
Cai, Meng‐Ting, Lei Ren, Zhide Guo, et al.. (2015). PET monitoring angiogenesis of infarcted myocardium after treatment with vascular endothelial growth factor and bone marrow mesenchymal stem cells. Amino Acids. 48(3). 811–820. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026